Celltrion, Inc. (KOSE: A068270)
Health Care · Biotechnology · KR
₩192,300.00
-4.33% today · +16.2% 1Y
Celltrion, Inc. (KOSE: A068270) operates in the Biotechnology industry within the Health Care sector. The company is valued at $31.82B.
Over the last twelve months the share price has gained 16.2%, trading between 158.50K and 239.05K.
Tweenvest scores Celltrion, Inc. across four factors: quality 74/100, value 55/100, growth 73/100, dividend 42/100. Its strongest factor is quality.
A068270 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.82B
- Revenue (TTM)
- $3.16B
- P/E
- 28.11
- EPS
- 6,841.88
- Dividend yield
- 0.37%
- Beta (5Y)
- 0.30
- 52-week high
- ₩239,047.62
- 52-week low
- ₩158,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 229.33M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $441.75 | +0.55% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.61 | +0.34% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €883.80 | -2.02% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.00 | -1.43% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.